The latest findings on oxytocin — a.k.a. the ‘trust hormone’ — secure its position as a frontrunner among emerging treatments for autism.
Efforts to ease the symptoms of autism are beginning to ramp up, with promising candidates in various stages of testing.
When thinking about themselves, adults with autism have lower activity in two specific brain regions than do healthy controls, according to an imaging study published in the February issue of Brain.
A class of medications widely used during pregnancy to treat asthma and prevent early labor increases the baby’s risk of autism and other psychiatric disorders, according to a controversial review in the American Journal of Obstetrics and Gynecology.
Genetic variations that tweak the brain’s release of oxytocin — a hormone involved in social bonding and establishing trust — may increase the risk of developing autism or traits of the disorder, according to three new studies published in the past few months.
A large clinical trial to test the first drug specifically designed to treat autism is under way at 12 sites across the United States.
An early intervention method called the Early Start Denver Model can help children with autism improve their language and behavioral skills, and raise their intelligence quotients, according to a study published in Pediatrics.
Astropolis, a dynamic video game, allows for the unprecedented testing of children with autism on a variety of cognitive skills, all at once, without the artificial, boring and anxiety-ridden setup of a typical psychology lab.